Breo Ellipta 200 ug/1 (Fluticasone Furoate and Vilanterol Trifenatate POWDER) 200 ug/1

Breo Ellipta 200 µg/1 is a combination inhaler containing fluticasone furoate and vilanterol trifenatate. It is used for managing respiratory conditions like asthma and COPD. This powder inhaler is designed for easy inhalation, providing relief and control of symptoms.

Strength

200 ug/1

Pack Size

1 TRAY in 1 CARTON (0173-0882-10) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Breo Ellipta 200 µg/1 is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). The combination of fluticasone furoate, a corticosteroid, and vilanterol trifenatate, a long-acting beta-agonist, works to reduce inflammation and relax the muscles in the airways. This helps to improve breathing and manage symptoms such as wheezing, shortness of breath, and coughing. People often ask, 'What is Breo Ellipta used for?' It is typically prescribed for long-term control rather than immediate relief of acute symptoms.

Side Effects

Common effects of using Breo Ellipta 200 µg/1 may include throat irritation, headache, and hoarseness. Some users might experience a taste disturbance or nasal congestion. These effects are generally mild and temporary. It is important to use the inhaler as directed to minimize potential discomfort and maximize the benefits.

Precautions & Warnings

Breo Ellipta 200 µg/1 should be used with caution in individuals with certain medical conditions, such as heart disease or diabetes. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Regular monitoring may be necessary to ensure the medication is working effectively and to manage any potential side effects.

Avoid Interactions

Breo Ellipta 200 µg/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be moderated, as it may exacerbate some side effects.

Frequently Asked Questions

Breo Ellipta is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).

Breo Ellipta should be used as directed by your healthcare provider. Typically, it is inhaled once daily.

Common side effects may include throat irritation, headache, and hoarseness. These effects are usually mild and temporary.

No, Breo Ellipta is designed for long-term control of symptoms and not for immediate relief.

Breo Ellipta should be used with caution in individuals with certain medical conditions, such as heart disease or diabetes.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.